Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 4—April 2021
Dispatch

Improving Treatment and Outcomes for Melioidosis in Children, Northern Cambodia, 2009–2018

Arjun Chandna1Comments to Author , Moritz Bonhoeffer1, Thyl Miliya, Keang Suy, Sena Sao, and Paul Turner
Author affiliations: Angkor Hospital for Children, Siem Reap, Cambodia (A. Chandna, M. Bonhoeffer, T. Miliya, K. Suy, S. Sao, P. Turner); University of Oxford, Oxford, UK (A. Chandna, P. Turner)

Main Article

Figure 2

Proportion of 306 surviving children who had culture-confirmed melioidosis and completed >12 weeks of eradication therapy, northern Cambodia, 2009–2018. Shaded area indicates 95% CIs for the linear trend line (R = 0.8; p = 0.006).

Figure 2. Proportion of 306 surviving children who had culture-confirmed melioidosis and completed >12 weeks of eradication therapy, northern Cambodia, 2009–2018. Shaded area indicates 95% CIs for the linear trend line (R = 0.8; p = 0.006).

Main Article

1These authors contributed equally to this article.

Page created: December 06, 2020
Page updated: March 18, 2021
Page reviewed: March 18, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external